| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 80, 3351-3355, Copyright © 1995 by Endocrine Society
ARTICLES |
H Bismar, I Diel, R Ziegler and J Pfeilschifter
Department of Internal Medicine, University of Heidelberg, Germany.
Studies on circulating human mononuclear cells and rodents have suggested that cytokines such as interleukin-1 (IL-1) and IL-6 may be paracrine mediators of postmenopausal bone loss. However, the assumption that the concentration of these cytokines is increased in the local bone microenvironment of postmenopausal women is still unproved. To address this question, we aspirated bone marrow from the iliac crest of 40 women during surgery for localized breast cancer and analyzed cytokine release in short term cultures. Cytokine levels in the cell supernatants from premenopausal (n = 12) and late postmenopausal (n = 18) subjects were not significantly different. Bone marrow cells from women who had discontinued estrogen replacement within 1 month before aspiration (n = 5) secreted significantly more IL- 1 alpha, tumor necrosis factor-alpha, IL-6, prostaglandin E2, and granulocyte-macrophage colony-stimulating factor than bone marrow cells from either premenopausal or late postmenopausal subjects. Increased levels of IL-6, prostaglandin E2, and granulocyte-macrophage colony- stimulating factor were also observed in cultures from women who were within 5 yr of natural menopause (n = 5). Our data show that estrogen withdrawal is associated with an increased potential of human bone marrow cells to release bone-resorbing cytokines and strengthen the hypothesis that these cytokines may play a role in the accelerated bone resorption after menopause.
This article has been cited by other articles:
![]() |
C. A. Blum, B. Muller, P. Huber, M. Kraenzlin, C. Schindler, C. De Geyter, U. Keller, and J. J. Puder Low-Grade Inflammation and Estimates of Insulin Resistance during the Menstrual Cycle in Lean and Overweight Women J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3230 - 3235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Flynn, B. K. McFarlin, M. D. Phillips, L. K. Stewart, and K. L. Timmerman Toll-like receptor 4 and CD14 mRNA expression are lower in resistive exercise-trained elderly women J Appl Physiol, November 1, 2003; 95(5): 1833 - 1842. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in Proinflammatory Cytokine Activity after Menopause Endocr. Rev., February 1, 2002; 23(1): 90 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. N. Messingham, S. A. Heinrich, and E. J. Kovacs Estrogen restores cellular immunity in injured male mice via suppression of interleukin-6 production J. Leukoc. Biol., December 1, 2001; 70(6): 887 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Scheidt-Nave, H. Bismar, G. Leidig-Bruckner, H. Woitge, M. J. Seibel, R. Ziegler, and J. Pfeilschifter Serum Interleukin 6 Is a Major Predictor of Bone Loss in Women Specific to the First Decade Past Menopause J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2032 - 2042. [Abstract] [Full Text] |
||||
![]() |
R. A. Nelson, A. M. Levine, and L. Bernstein Reproductive Factors and Risk of Intermediate- or High-Grade B-Cell Non-Hodgkin's Lymphoma in Women J. Clin. Oncol., March 1, 2001; 19(5): 1381 - 1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Manolagas Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis Endocr. Rev., April 1, 2000; 21(2): 115 - 137. [Abstract] [Full Text] |
||||
![]() |
S. Pervin, R. Singh, M. E. Rosenfeld, M. Navab, G. Chaudhuri, and L. Nathan Estradiol Suppresses MCP-1 Expression In Vivo : Implications for Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 1998; 18(10): 1575 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cheleuitte, S. Mizuno, and J. Glowacki In Vitro Secretion of Cytokines by Human Bone Marrow: Effects of Age and Estrogen Status J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2043 - 2051. [Abstract] [Full Text] |
||||
![]() |
I. Gorai, Y. Taguchi, O. Chaki, R. K. M. Nakayama, B. C. Yang, S. Yokota, and H. Minaguchi Serum Soluble Interleukin-6 Receptor and Biochemical Markers of Bone Metabolism Show Significant Variations During the Menstrual Cycle J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 326 - 332. [Abstract] [Full Text] |
||||
![]() |
R. S. Weinstein, R. L. Jilka, A. M. Parfitt, and S. C. Manolagas The Effects of Androgen Deficiency on Murine Bone Remodeling and Bone Mineral Density Are Mediated via Cells of the Osteoblastic Lineage Endocrinology, September 1, 1997; 138(9): 4013 - 4021. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |